Although some findings are contradictory (Pruszynska-Oszmalek et al. 2013; Ren et al. 2013), it is becoming clear that plasma obestatin levels are disturbed following the development of obesity and diabetes (Seim et al. 2011; Trovato et al. 2014). This evidence concerns the gene GHRL and obesity due to melanocortin 4 receptor deficiency.